Benzinga | Nov 2, 2020 04:15PM EST

Medifast Q3 EPS $2.91 Beats $2.46 Estimate, Sales $271.50M Beat $240.62M Estimate

Medifast (NYSE:MED) reported quarterly earnings of $2.91 per share which beat the analyst consensus estimate of $2.46 by 18.29 percent. This is a 120.45 percent increase over earnings of $1.32 per share from the same period last year. The company reported quarterly sales of $271.50 million which beat the analyst consensus estimate of $240.62 million by 12.83 percent. This is a 42.85 percent increase over sales of $190.06 million the same period last year.